Showing 1 - 10 of 531
Persistent link: https://www.econbiz.de/10001394280
Persistent link: https://www.econbiz.de/10002141188
Persistent link: https://www.econbiz.de/10006988068
Persistent link: https://www.econbiz.de/10006246890
High-tech firms are built much more on the intellectual capital of key personnel than on physical assets, and firms built around the best scientists are most likely to be successful in commercializing breakthrough technologies. As a result, such firms are expected to have higher market values...
Persistent link: https://www.econbiz.de/10012471587
High-tech firms are built much more on the intellectual capital of key personnel than on physical assets, and firms built around the best scientists are most likely to be successful in commercializing breakthrough technologies. As a result, such firms are expected to have higher market values...
Persistent link: https://www.econbiz.de/10013243425
High-tech firms are built much more on the intellectual capital of key personnel than on physical assets, and firms built around the best scientists are most likely to be successful in commercializing breakthrough technologies. As a result, such firms are expected to have higher market values...
Persistent link: https://www.econbiz.de/10005828750
A growing body of evidence has documented the critical role that entrepreneurs play in fostering economic growth. But entrepreneurs can only be expected to take risks in ‘open settings’, where individuals and firms are free to contract with one another. In this important book,...
Persistent link: https://www.econbiz.de/10011172987
Commercializing knowledge involves transfer from discovering scientists to those who will develop it commercially. New codes and formulae describing discoveries develop slowly-with little incentive if value is low and many competing opportunities if high. Hence new knowledge remains naturally...
Persistent link: https://www.econbiz.de/10009198166
We examine the effects of university-based star scientists on three measures of performance for California biotechnology enterprises: the number of products in development, the number of products on the market, and changes in employment. The “star†concept which Zucker, Darby, and...
Persistent link: https://www.econbiz.de/10010537758